throbber
C L I N I C A L A N D E X P E R I M E N T A L
`
`OPTOMETRY
`
`REVIEW
`Dry eye: an update on clinical diagnosis,
`management and promising new treatments
`
`Julie M Albietz BAppSc(0ptom) (Hons)
`PhD
`School of Optometry, Queensland
`University of Technology
`
`Accepted for publication: 20 December
`2000
`
`Dry eye conditions are prevalent with one in four to five patients presenting to eye care
`practitioners having dry eye signs and/or symptoms. An intimate relationship exists
`between the ocular surface and the tear film. The cycle of tear film instability and
`ocular surface damage characteristic of dry eye conditions suggests that dry eye repre-
`sents a dysfunction of an integrated ocular surface-lacrimal gland unit. Therefore, dry
`eye is a multifactorial condition and ari approach based on clinical subtypes is required
`for diagnosis and management. There is increasing evidence that inflammation is a
`contributing and exacerbating factor in dry eye conditions and anti-inflammatory or
`immunomodulatory therapy for chronic dry eye conditions may facilitate ocular surface
`healing. Other promising new treatments for dry eye include new generation artificial
`tear polymers and preservative systems, secretagogues, topical androgen supplements
`and surgical techniques for ocular surface reconstruction.
`(Clin Exp Optom 2001; 84: 1: 4-18)
`
`Key words: artificial tear supplements, dry eye, dry eye treatments, evaporative dry eye, ocular surface disorders, tear deficient dry
`eye, tear film
`
`The concept of the 'dry eye' was initially
`used to describe symptoms of ocular irri-
`tation due to insufficiency in lacrimal
`gland aqueous tear secretion and lead-
`ing to ocular surface damage. Keratocon-
`junctivitis sicca was the term given to the
`ocular surface disease that develops in
`patients with aqueous tear deficiency.
`Over the past 30 years, knowledge of the
`pathogenic factors involved in dry eye
`states has grown significantly. Many pa-
`tients with dry eye symptoms produce a
`normal quantity of aqueous tears hut
`have other tear film and/or ocular sur-
`face disorders.'.' The definition of dry eye
`has been e x p a n d e d to include any
`anomaly in a gland associated with tear
`production or an anomaly in lid and/or
`
`blinking function in which the quality
`and/or quantity of the tear film is ad-
`versely affected and there is an inability
`to maintain a healthy ocular surface.2s
`The multifactorial nature of dry eye con-
`ditions has produced the term 'tear film
`and ocular surface disorders" as an alter-
`native to the term dry eye. This recognises
`the intimate relationship between the om-
`lar surface and the tear film and the cycle
`of tear film instability and ocular surface
`damage characteristic of dry eye. It also
`acknowledges recent suggestions that dry
`eye represents a dysfunction of an inte-
`grated ocular surface-lacrimal gland unit.","
`The ocular surfxe (conjunctiva, cornea,
`accessory lacrimal glands and meibomian
`glands), the lacrimal gland and the inter-
`
`connecting neural reflex loops appear to
`comprise a tightly integrated functional
`unit, the parts of which ac.t together and
`not in isolation.' Decreased lacrimal gland
`secretion damages the ocular surhce,
`which creates a negative feedback loop re-
`sulting in damage to the lacrimal gland.
`There are probably several mechanisms by
`which this feedback occurs:
`1. interruption or damage to the sensory
`corneal nerves
`2. damage to the lacrimal gland
`3. alteration of growth factor levels in the
`lacrimal gland following corneal dam-
`age.
`Contact lenses and corneal refractive sur-
`gery are additional factors that may create
`negative 'feedback to the lacrimal gland.'
`
`Clinical arid Expcrimental Opromrtry 84.1 January-Febi-uary 2001
`4
`
`APOTEX 1029, pg. 1
`
`

`

`Dry eye type
`
`Main Causes
`
`Tear deficient dry eye
`
`Evaporative dry eye
`
`1. Sjbgren's syndrome
`2. Non-Sjbgren's lacrimal disease
`Ageing
`Menopause
`Medicamentosa
`Cicatricial disease
`Neurotrophic keratitis
`
`Meibomian gland disease
`Lid surfacing/blinking anomalies
`Contact lens related
`Chronic allergyhoxicity
`Cicatricial ocular surface disease
`
`Table 1. Classification of dry eye: main subtypes and main causes
`(adapted from 3,
`
`The National Eye Institute/Industry
`Workshop on Clinical Trials of Dry Eye3
`has recommended a revision of the classi-
`fication of dry eye, given its multifxtorial
`nature. The major dry eye categories pro-
`posed were tear deficient dry eye and
`evaporative dry eye. In the tear deficient
`category were Sjogren's syndrome and
`non-Sjogren's syndrome forms of aqueous
`tear deficiency. Evaporative forms of dry
`eye were oil deficient (meibomian gland
`anomalies), lid surfacing and blinking
`anomalies, chronic allergy/toxicity, con-
`tact lens-related anomalies and cicatricial
`ocular surface disease (Table 1).
`Dry eye is a prevalent condition with
`one in four patients presenting for eye
`examination manifesting dry eye symp-
`toms7 and 10 to 18 per cent being diag-
`nosed with dry eye depending on the
`diagnostic criteria
`The prevalence
`of dry eye has increased in recent years
`due to the general ageing of the popula-
`tion,'O increased medication use '('and in-
`crease in environmental allergens and
`irritants.".I2 It was estimated that there
`were 30 million dry eye sufferers in the
`United States of America in 1990 and the
`incidence of dry eye increased to 59 mil-
`lion in 1997." In addition to symptoms
`of chronic ocular surface irritation, dry
`eye is characterised by blurred vision,
`
`increased risk of infecti~n,'~.'' medication
`contact lens intoleranceI6 and
`progressive ocular surface disease, scar-
`ring and corneal morbidity.'"-"' Hence
`correct diagnosis and appropriate man-
`agement of dry eye is essential.
`
`THE TEAR FILM AND OCULAR
`SURFACE
`
`The tear film is composed of an external
`lipid layer, an aqueous layer, a semi-solid
`conjunctival goblet cell mucous layer and
`the non-goblet epithelial mucin layer (the
`glycocalyx). The lipid layer is produced
`by the meibomian glands and its princi-
`pal role is to reduce tear film evapora-
`tion.2' The aqueous layer contains electro-
`lytes, glucose, antibacterial proteins,
`antibodies a n d glycoproteins a n d is
`secreted primarily by the lacrimal gland.22
`The inner layer of the tear film is com-
`posed of mucin secreted by the goblet
`cells of the c~njunctiva"~'~ and the non-
`goblet epithelial cells of the cornea" and
`
`c o n j ~ n c t i v a . ~ ~ ~ * ~ The superficial epithelial
`cells have microvilli and microplicae that
`are covered by the glycocalyx, a non-goblet
`cell mucin, which appears to anchor the
`goblet cell m u c h to the underlying sur-
`face epithelium and may facilitate tear
`film spread and stabilisation.25 The thick-
`
`Dry eye Albietz
`
`ness of the tear film remains controver-
`sial. Interferometric estimates of 40
`microns" (with the bulk of the tear film
`being mucin and the tear film thought
`to be a hydrated mucin gel) and more
`recently three microns" have been re-
`ported.
`The ocular surface epithelium is non-
`keratinised and multi-layered with mor-
`phological variations in the corneal,
`limbal and conjunctival epithelia."","' The
`corneal and conjunctival epithelial barrier
`functions are formed and maintained by
`tight, intercellular desmosomes between
`the adjacent superficial cells.92,"" The
`limbal epithelium is thought to contain
`the stem cells of the corneal epithelium
`and serves as the junctional epithelium to
`prevent conjunctival epithelial ingrowth
`onto the corneal surface during the heal-
`ing of a large corneal epithelial defe~t.:'~.''~
`The limbal epithelium represents the true
`germinative zone for corneal epithelium.
`In normal conditions, the epithelial cells
`continuously migrate from the limbus
`toward the corneal centre. This process is
`accelerated in epithelial wound healing.'iti
`As the limbal epithelial stem cells have
`very slow cycling time, loss or damage to
`the limbal area from chemical or surgical
`trauma, chronic inflammation or contact
`lens-related pathology can result in limbal
`stem cell d.eficiency a n d a gradual
`conjunctivalisation of the ~ornea.'~'
`Numerous hormones, growth factors,
`retinoids, cytokines a n d reciprocal
`receptors for these factors have been iden-
`tified in the lacrimal glands and on the
`ocular surface."-'2 The meibomian glands
`and lacrimal glands appear to require
`androgens to support their normal func-
`tion.4'-"" Androgen loss may play a critical
`role in the initiation of meibomian gland
`dysfunction, and decreases in androgen,
`particularly evident in Sjogren's syn-
`drome, may serve to lessen tissue function
`as well as to promote (but not cause) the
`autoimmune process in the lacrimal
`gland, 49.45 Programmed cell death (or
`apoptosis) of lacrimal gland acinar cells
`may be the primary event proceeding the
`damage to the lacrimal gland in tear defi-
`cient dry eye, even in the absence of
`autoimmune disease.'"
`
`Clinical and Experimental Optometry 84.1 January-February 2001
`5
`
`APOTEX 1029, pg. 2
`
`

`

`Dry eye Alhietz
`
`DRY EYE SUBTYPES: CAUSES AND
`PREVALENCE
`
`Tear deficient dry eye
`Aqueous tear deficient dry eye affects up
`to three per cent of the population and is
`more prevalent in females and the eld-
`erly."~''-"' The lacrimal gland abnormalities
`include lack of stimulation of tear secre-
`tion, inflammation and destruction of the
`lacrimal gland and accessory lacrimal
`glands and scarring or occlusion of the
`lacrimal gland secretory ducts."" The most
`severe forms of aqueous tear deficiency
`are due to destruction or absence of the
`lacrimal gland and include Sjogren's syn-
`drome," human immunodeficiency syn-
`drome," graft versus host disease"3 and
`congenital or surgical removal of the lac-
`rimal gland.' Cicatricial diseases such as
`trachoma, chemical burns, Stevens-
`Johnson syndrome and ocular cicatricial
`pemphigoid can also cause a severe sec-
`ondary aqueous tear deficiency through
`the scarring, narrowing and obliteration
`of the lacrimal gland and accessory
`lacrimal gland secretory ducts.'
`
`AUTOIMMUNE AQUEOUS TEAR
`DEFICIENCY
`Sjogren's syndrome is the main cause of
`severe aqueous tear deficiency and has a
`prevalence of approximately one per cent,
`with the majority of sufferers being
`female." '' The condition is a slowly-
`progressing, chronic multi-system condi-
`tion affecting excretory glands in all pa-
`tients and extra-glandular organs in some
`patients with the major features being
`aqueous tear deficiency and xerostomia
`(dry mouth) .i4 Approximately half of the
`cases are associated with other connective
`tissue disorders, the most common being
`rheumatoid arthritis and others include
`systemic lupus erythematosis, scleroderma
`and polymyosis.55 The disease process is
`extremely complex and the ocular com-
`ponent is characterised by lacrimal gland
`inflammation, conjunctival inflammation
`and severe ocular surface desiccation, in-
`cluding punctate keratitis, mucous fila-
`ments, corneal ulceration and scleritis'h ''
`(Figure 1 ) . Although the exact mecha-
`
`nism that triggers Sjogren's syndrome is
`unknown, it seems that some events cause
`changes in the cell membranes of the lac-
`rimal and salivary glands and the immune
`system then attacks these glands as if they
`were f ~ r e i g n . ' ~ The infiltrative cells seen
`in lacrimal gland biopsy are specific to
`Sjogren's syndrome and they differ in type
`and number from the infiltration that
`occurs as a function of ageing.'" Recent
`research indicates that androgen defi-
`ciency may promote the progression of
`Sjogren's syndrome and associated lac-
`rimal gland inflammation but does not
`cause Sjogren's syndrome or aqueous tear
`deficiency in human and animal model^.^'
`The relative roles of viral infections such
`as Epstein-Barr virus, cytornegalovirus and
`herpes virus-6 in the pathogenesis of
`Sjogren's syndrome have been suggested
`and there is evidence that these viruses
`activate or precipitate immune responses
`in the lacrimal glands, leading to
`increased inflammation."'-h'
`
`NON-AUTOIMMUNE AQUEOUS TEAR
`DEFICIENCY
`Less severe forms of aqueous tear defi-
`ciency occur due to abnormalities of the
`regulation of tear secretion. These may be
`precipitated by ageing and age-related
`alterations in hormone level^."^"^ Diffuse
`fibrosis, diffuse atrophy and periductdl
`fibrosis predominantly found in elderly
`women suggest a relationship with aqiie-
`ous tear deficiency in post-menopausal
`women.' Many commonly-prescribed oral
`and topical medications may reduce aqire-
`ous tear production including topical and
`systemic anti-histamines, tricyclic anti-
`depressants, topical and systemic beta-
`blockers, the oral contraceptive pill and
`systemic and topical non-steroidal anti-
`inflammatory agents.'''
`Loss of corneal sensitivity as is observed
`in diabetes,65 excimer laser photorefractive
`keratectomy and L.ASIK66 and contact lens
`wear,67 has been implicated in causing dry
`eye conditions through reduced reflex
`tearing'" and reduced blink rate.'' Re-
`duced tear secretion may actually lead to
`reduction in corneal sensitivity,6y thereby
`creating a cycle of declining sensitivity and
`declining tear production.
`
`Evaporative dry eye
`
`MEIBOMIAN GLAND ANOMALIES
`Meibomian gland anomalies cause the
`most prevalent form of evaporative dry eye
`with a prevalence of four per cent for lipid
`anomaly dry eye.* Approximately 40 per
`cent of the general population has signs
`of meibomian gland dysfunction'" and a
`100 per cent incidence of poor tear film
`stability and ocular surface staining has
`been reported in subjects with chronic
`meib~mianitis.~' An increased prevalence
`of meibomian gland dysfunction occurs
`with age7" due to normal ageing changes
`in the lids and meibomian glands." The
`most common causes of meibomian gland
`dysfunction are damage or destruction of
`meibomian glands due to meibomian
`seborrhoea," meibomianitis" and senile
`or cicatricial meibomian gland changes.''
`Less common causes of meibomian gland
`disease include congenital absence of
`meibomian glands,' replacement of
`meibomian glands due to congenital or
`acquired distichiasis" and meibomian
`n e ~ p l a s i a . ' ~ The dermatological condi-
`tions, acne rosacea and seborrhoeic der-
`matitis, have a 51 per cent and 74 per cent
`incidence of meibomianitis, respectively."
`Stagnation of the meibomidn gland lipids
`in meibomian gland dysfunction gives bac-
`terial lipase an opportunity to break down
`the meibomian lipid into free fatty acids
`which cause increased tear film evapora-
`tion, an unstable tear film,'> marginal
`keratitis a n d a superficial punctate
`keratopathy7' (Figures 2, 3 arid 4).
`
`CHRONIC ALLERGY
`Chronic allergy destabilises the tear film
`and can induce ocular surface di~ease.""~
`An allergic history has been reported by
`36 per cent of dry eye subject^.^ The aller-
`gic inflammatory mechanism in giant cell
`papillary conjunctivitis (GPC) causes ex-
`cessive mucin production through hyper-
`plasia of goblet cells and hypermitosis of
`non-goblet epithelial cells.7h 77 In addition,
`decrease in tear production has been re-
`ported in subjects who have nasal mucosal
`pathology following chemical destruction
`or chronic allergy resulting in reduction
`or loss of the nasolacrimal reflex." Vernal
`
`Clinical and Experimental Optometry 84.1 January-FehrudI-y 2001
`6
`
`APOTEX 1029, pg. 3
`
`

`

`Dry eye Albz
`
`Figure 1. Chronic aqueous tear deficiency in Sjogren’s syndrome.
`Corneal filaments and widespread staining are characteristic features.
`Inferior neovascular changes are secondary to aqueous tear deficiency
`and are due to chronic inflammation of the meibomian glands.
`
`Figure 2. Marginal infiltrative keratitis associated with meibomii
`seborrhoea
`
`Figure 3. Particulate meibomian gland debris in the tear film. The
`significant nasal pterygium will exacerbate the evaporative dry eye
`condition caused by the meibomian gland dysfunction.
`
`Figure 4. Trichiasis, madarosis, lid thickening and telangectas
`associated with chronic meibomian gland dysfunction. Staphylococ
`blepharitis is also present.
`
`Figure 5. Micro- and macropapillae in vernal kerato-conjunctivitis. The
`larger papillae can act as a foreign body, further disrupting the ocular
`surface.
`
`Figure 6. Lid surfacing anomalies causing increased tear evaporatiot
`large fleshy pterygium and senile ectropion
`
`Clinical and Experimental Optometry 84.1 January-Fchrudry 200 I
`7
`
`APOTEX 1029, pg. 4
`
`

`

`Dry eye Albietz
`
`keratoconjunctivitis is associated with a 38
`per cent incidence of dry eye7' (Figure 5).
`
`OCULAR SURFACE TOXICITY
`Toxic effects of topical therapeutic agents
`can result in ocular surface damage, in-
`flammation and tear film disruption.H"
`Preservatives such as benzalkonium chlo-
`rideX'.Hi . and cetrimideH4 are known to be
`toxic to the epithelium. Intrinsic toxicity
`ran also result from the active ingredient
`in the medication itself. For example,
`long-term use of topical anti-glaucoma
`medications can induce and/or exacer-
`bate dry eye conditions through squamous
`metaplasia, loss of goblet cells and ocular
`surface inflanimation.K'X'
`
`CONTACT LENS WEAR
`Dry eye is prevalent in contact lens weaF ''
`with 20 to 30 per cent of contact lens wear-
`ers having dry eye symptoms.q" Contact
`lens wear is associated with increased
`mucous production,' reduced blink fre-
`quency,'" blink inefficiency," 3 and 9
`o'clock staining,'" reduced tear break-up
`time," increased tear evaporation" and
`increased tear osmolarity," all of which
`can produce and/or exacerbate dry eye
`signs and symptoms.
`
`CICATRICIAL OCULAR SURFACE DISEASE
`Cicatricial ocular surface diseases, al-
`though rare, can result in gross tear film
`instability through destruction of ocular
`surface epithelia, loss of goblet cells and
`cicatricial changes such as symblepharon
`and scarring of lacrimal gland ductiiles.lq
`These conditions are potentially the most
`vision-threatening of all dry eye types with
`limbal stem cell loss and conjunctival-
`isation of the cornea being potential con-
`sequences of cicatricial disease.
`
`LID SURFACING ANOMALIES
`Dry eye due to lid surfacing anomalies
`affects approximately two per cent of the
`population. Any anomaly preventing or
`restricting complete lid closure and nor-
`mal blinking patterns can disrupt tear film
`stability, increase tear evaporation and in-
`iuce ocular surface staining."' Potential
`Iauses are ectropion, entropion, large
`>terygia,"+ facial palsies, symblepharon,'
`
`nocturnal
`blinking,
`incomplete
`lagophthalmos,g6 lid retraction and prop-
`
`tosis in thyroid d i ~ e a s e , ~ ' involuniary
`blepharospasm,gH dermatochalasis,gq
`conjunctivochalasis,'"" lower lid laxity'"'
`
`and contact lens wear.L6~q1~10L? Extensions of
`the interblink period due to intense ion-
`centration during close work and compu-
`
`ter work con~entration"'","'~ and in Parkin-
`son's disease may lead to dessication of
`the ocular surface." Reduction in lid ri-
`gidity and tonus occurs with age.lo5 Dellen
`occur in lid surfacing anomalies in asso-
`ciation with pterygia, pingueculae and
`contact lens wear I H (Figure 6).
`
`ENVIRONMENTAL INFLUENCES
`
`Environmental factors such as dehydrat-
`ing temperature-controlled environ-
`ments"' can cause or contribute to
`evaporative dry eye conditions. Several
`terms have been used to describe the ocu-
`lar irritation, poor tear film stability and
`ocular surface desiccation associated with
`the poor indoor air-quality in tempcra-
`ture-controlled office environments.
`These include 'pollution keratoconjunc-
`tivitis',lL 'office dry eye syndrome' and
`'sick building syndrome'."'" Studies irtdi-
`cate that 35 per cent to 48 per cent of in-
`dividuals working in such environments
`are afflicted by the ocular signs and/or
`symptoms. lo'' ""
`
`The multifactorial nature of
`dry eye
`A dry eye condition can have multiple
`causative mechanisms."'" A common ex-
`ample is the elderly, post-menopausal,
`te ar-d e fi c i en t pa tie n t taking systemic
`medications that further reduce tear pro-
`duction.l"q~"" In chronic forms of dry eye,
`the complications from the primary con-
`dition can cause a secondary source of tear
`film instability and a further exacerbation
`of the ocular surface disease. An associa-
`tion between tear deficient dry eye and
`evaporative dry eye has been reported by
`several authors. McCulley and coworkers"
`reported a 25 per cent to 40 per cent inci-
`dence of aqueous tear deficiency in sub-
`jects with conditions of meibomian gland
`dysfunction. Chronic lid inflammation
`
`from meibomian gland dysfunction may
`cause scarring of lacrimal and accessory
`lacrimal gland ductules, subsequently re-
`sulting in deficiency in aqueous tear pro-
`duction14 (Figure 4). Alternatively, con-
`centration of tear proteins at the inferior
`lid margin resulting from reduced aque-
`ous tear production can induce inflamma-
`tion in meibomian glands." Meibomian
`gland anomalies are commonly reported
`in Sjogren's syndrome."'.11'
`
`The tear film and ocular surface
`in dry eye
`Specific deficiencies of tear components
`have been identified in dry eye. These in-
`clude deficiencies in tear proteins (for ex-
`ample, lactoferrin, lysozyme, preal-
`bumin) 114.114 a n d growth factors (for
`example, epidermal growth factor, trans-
`forming growth factors)'I5 and increase in
`inflammatory cells."l,"h
`In all forms of dry eye, irrespective of
`the mechanism, the conjunctival ocular
`surface undergoes squamous metaplasia,
`a progressive transition to a non-secretory,
`keratinised epithelium.xi',l'7.'1X The loss of
`conjunctival goblet cells appears to he a
`very sensitive indicator of ocular surface
`disease.'""' Goblet cell loss occurs within
`weeks of the onset of dry eye
`There also appears to be an alteration to
`conjunctival mucin distribution and/or
`chemical properties in dry eye."' Inflam-
`matory mechanisms are the most likely
`cause for the loss of goblet cells in dry
`eye.l".ll9 Up regulation of immune-
`mediated markers of conjunctival ocular
`surface inflammation and infiltration of
`T-lymphocytes occur in the conjunctival
`epithelium in both Sjogren's syndrome
`and non-Sj(jgren's dry eYe,!i~,Kl.l??~121~ The in-
`flammatory mediators released as a result
`of cellular damage appear to exacerbate
`the ocular surface and lacrinial gland in-
`flammation and damage in dry eye."7~1:"'
`
`CLINICAL DRY EYE ASSESSMENT
`
`While there are many tests for dry eye,
`there remains a great disparity among the
`symptoms and signs in many dry eye pa-
`tients. Determining the cause of dry eye
`when minimal clinical signs are present
`
`Clinical and Exprririirntdl Optometry 84.1 January-February 200 I
`8
`
`APOTEX 1029, pg. 5
`
`

`

`Dry eye Albietr
`
`is difficult and the diagnosis is compli-
`cated further when there is a lack of cor-
`relation between symptoms and objective
`tests1'' In an attempt to overcome these
`problems and to standardise the diagnos-
`tic criteria for dry eye, the National Dry
`Eye Institute/Industry report has pro-
`duced the following global criteria' for
`clinical diagnosis of dry eye:
`1. a validated test of dry eye symptoms
`2. reduced tear film stability
`3. ocular surface staining
`4. tear hyperosmolarity.
`
`Symptoms
`Although dry eye is represented by vari-
`ous dysfunctional states involving the tear
`film, ocular surface, lids and blinking, dry
`eye symptoms are generally not subtype
`specific. Commonly reported dry eye
`symptoms are grittiness, foreign body sen-
`sation, burning, soreness, stinging,
`scratchiness, dryness, blurry vision, a 'film
`over the eyes', paradoxical reflex tearing
`and photophobia,lH.20.Y~.."~
`Clinical evaluation of dry eye should in-
`clude an assessment of subjective symp-
`toms and functional lifestyle, through the
`use of a well-designed and validated dry
`eye questionnaire." Until recently, the
`McMonnies Dry Eye Symptom Survey was
`the only questionnaire to meet these
`requirements and provide a formal aid to
`dry eye history-taking in clinical prac-
`
`t i ~ e . " ' . ~ ~ ~ The recently introduced Ocular
`Surface Disease Index (OSDI)IS5 is a
`12-item questionnaire designed to provide
`a rapid assessment of the symptoms of
`ocular irritation with dry eye disease and
`their impact on visual function. The
`OSDI correlates significantly with the
`McMonnies questionnaire and appears to
`be a valid and reliable method of measur-
`ing the severity of dry eye disease and pos-
`sesses the necessary psychometric proper-
`ties to be used as an end point in clinical
`trials.136 While the OSDI has not yet been
`published,
`its advantage over
`the
`McMonnies Survey is that it is not biased
`towards diagnosis of aqueous tear deficiency.
`Tear film stability
`Tear film instability is a non-specific test
`for dry eye. All tear film stability tests have
`
`poor repeatability and a mean of multi-
`ple measures is recommended."'A recent
`study indicated a significant correlation
`between ocular surface discomfort and
`tear film break-up time in dry eye sub-
`jects.'?" The most common clinical meas-
`ure of tear film stability is fluorescein
`break-up time (FBUT) which has a refer-
`ence value of less than 10 seconds for dry
`eye."' As instillation of large volumes of
`fluorescein destabilise the tear film, an
`effort should be made to control the vol-
`ume of fluorescein instilled in the eye.
`The Dry Eye Test (DETTM) is a newly-
`released thin fluorescein strip which de-
`livers only one microlitre of fluorescein
`into the eye, compared to 10 microlitres
`for a standard fluorescein strip, hence im-
`proving the accuracy and reproducibility
`of FBUT measurements."" It is not yet
`available in Australia. Non-invasive meth-
`ods of tear film instability such as the
`keratometer mires and Keeler Tearscope
`PlusTu give longer tear film stability meas-
`ures and a value less than 20 seconds war-
`rants further investigation.
`
`Ocular surface staining
`Fluorescein and rose Bengal are the two
`most widely-used ocular surface stains.
`Rose Bengal stains dead and devitalised
`cells, mucous strands and areas where the
`mucous layer of the tear film is discon-
`tinuous."" Fluorescein lacks this ability to
`be blocked by tear constituents and dif-
`fuses rapidly into the stroma where cell
`to cell junctions are disrupted."'
`Fluorescein acts as a vital stain adhering
`to devitalised cells.'"' Unlike rose Bengal,
`fluorescein does not stain mucus.
`Lissamine green B is an alternative to rose
`Bengal that is more easily t01erated.l~"
`Lissamine green B is identical to rose Ben-
`gal in its staining properties but it stains
`blue on the ocular surface and it is easier
`to distinguish against an inflamed con-
`j u n ~ t i v a . " ~ It is not yet available in Aus-
`tralia.
`Fluorescein and rose Bengal staining are
`highly sensitive for dry eye diagnosis but
`mild staining has been found in 30 per cent
`to 40 per cent of normals."' Various semi-
`quantitative fluorescein and rose Bengal
`staining schemes have been described. The
`
`most widely used staining grading schemes
`are those proposed by Lemp,3 van
`
`Bji~terveldl~~ and the Oxford scores.14h
`The location of ocular surface staining
`can be a significant indicator of the cause
`of a dry eye c ~ n d i t i o n . " ~ ~ ' ) Examples
`include:
`1. Non-autoimmune aqueous tear defi-
`ciency is characterised by inter-
`palpebral staining, whereas in autoim-
`mune aqueous tear deficiency the
`staining is more widespread and may
`be confluent'" (Figure 1 ) .
`2. Meibomian gland anomalies are gen-
`erally associated with staining along the
`inflamed lid margins and 4 and 8
`o'clock corneal staining, where the
`inflamed lid margins meet.'47
`3. Lid surfacing anomalies are associated
`with staining in the region of ocular
`surface exposure, which is generally in-
`ferior in senile and cicatricial ectro-
`pion, lower lid laxity and nocturnal
`lagophthalmos, interpalpebral in cases
`of incomplete blinking, large fleshy
`pterygia and pingueculae or wide-
`spread in thyroid eye
`4. Staining of the plica semilunaris and
`caruncle is indicative of allergic condi-
`tions, where habitual eye rubbing and
`'mucus fishing' may develop.5"
`5 . Toxic papillary reactions are character-
`ised by widespread corneal staining
`extending inferonasally to the conjunc-
`tiva in non-contact lens wearers. A simi-
`lar pattern of staining is seen in contact
`lens wearers with toxic papillary reac-
`tions. However, the staining is more in-
`tense in the superior limbal region."
`6. Contact lens associated dry eye is most
`likely to be associated with a 3 and 9
`o'clock or 4 and 8 o'clock staining in
`rigid gas permeable contact lens wear
`or inferior corneal exposure staining
`in soft contact lens wearers. Any type
`of contact lens can be associated with
`non-specific widespread staining when
`soiled lenses are worn."'
`Tear film osmolarity
`Hyperosmolarity is a contributing mecha-
`nism in ocular surface damage and inflam-
`mation associated with aqueous tear
`deficiency and meibomian gland dys-
`
`Clinical and Experimental Optometry 84.1 January-February 2001
`9
`
`APOTEX 1029, pg. 6
`
`

`

`Dry eye Albirtz
`
`function." However, in the absence of
`a simple clinical technique to measure
`tear osniolarity, this diagnostic test will
`remain a research tool for the present.' ""
`
`Global dry eye diagnostic protocol
`Golding and Brennan"" researched the
`diagnostic accuracy of 20 common clini-
`cal tests for dry eye and determined that
`a protocol comprising the symptoms, sta-
`bility arid staining tests of McMonnies dry
`eye symptom survey score equal to or
`greater than 14, rose Bengal staining score
`of one or greater and FBUT less than 10
`seconds, gave an optimal dry eye diagnos-
`tic accuracy with sensitivity of 93 per cent
`and specificity of 100 per cent. Clinical
`differential diagnosis of dry eye types can
`h e made primarily o n the basis of
`biomicroscopic signs.x 'IiH
`
`CLINICAL DIAGNOSIS OF TEAR
`DEFICIENT DRY EYE
`
`Diagnostic work-up for tear deficiency
`should incorporate a detailed medication
`history (to identify medications inhibiting
`aqueous tear production), general health
`history (to identify related systemic con-
`ditions) and at least one test of tear secre-
`tion."' Tear secretion tests include the
`Schirmer and Jones tests, phenol red
`thread tear test (PRT) and fluoro-
`photometry. These tests have only fair
`reproducability.'"'~''' Hence, tear defi-
`ciency diagnosis cannot be made on the
`basis of tear secretion alone. The Schirmer
`I test'"' and Jones testl"'measure basal and
`reflex tear secretion, respectively, and are
`the most commonly-used clinical tests.""
`The Jones test involves application of topi-
`cal anaesthetic a few minutes before in-
`stillation of the Schirmer test strip into the
`lower fornix, whereas the Schirmer I test
`involves conjunctival stimulation and the
`Schirmer I1 test involves nasal stimula-
`tion.'% Normal values with and without
`anaesthetic are more than 5 mm over five
`minutes and more than 10 mm over five
`minutes, respectively.'54 Schirmer strips
`can cause significant patient discomfort
`and ocular surface disturbance when the
`poorly wetted strip fails to soften in a dry
`eye subject. lii
`
`The PRT test has been described as a
`measure of tear volume and turnover
`rather than basal tear secretion."" PRT test
`values have not been found to correlate
`with Schirmer test values.'"; Evaluation is
`made by measuring the quantity of tears
`absorbed into a fine cotton thread placed
`A normal value
`in the inferior
`of 24 mm over 15 seconds has been re-
`corded for a Caucasian population.'"" A
`PRT test value of less than 11 mm in
`15 seconds is diagnostic of aqueous tear
`deficiency."" The PRT test can effectively
`differentiate between tear deficient and
`non-tear deficient dry eye and between
`tear deficient dry eye and non-dry eye
`subjects. "Ix
`A number of biomicroscopic signs are
`specifically associated with tear deficient
`dry eye. These include a scant inferior tear
`meniscus,"g dull pre-corneal tear film
`specular reflection,'"" lid parallel conjuiic-
`ti"al folds, ' l 7 ' , ' 6 ' particulate matter in the
`tear film,"'" tear film mucous debris and
`mucin filament^.'"^
`Using fluorophotometry, tear flow and
`tear volume can he evaluated by measur-
`ing the decay of sodium fluorescein in
`the tear film after its topical applica-
`tion."" Tear turnover rate is approni-
`mately 42 per cent lower in dry eye sub-
`jects than in normals.""' The fluorescein
`cle

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket